RightFit
RecruitingPhase not listed

An External Control Arm Study in Non-Small Cell Lung Cancer

A Prospective Study to Generate Precision External Controls in Advanced or Metastatic Non Small Cell Lung Cancer Patients

Who can join

As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.

Age
18 Years and older
Sex
All sexes
Healthy volunteers
Not accepted
Compensation
Not stated

Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.

What to expect

No one can promise a trial will help you personally — that is what the research is trying to find out.

What participation involves

Not stated in the study description — ask the study team about visits and procedures.

Compensation
Not stated
  • Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
  • Participants are monitored closely by the research team throughout the study.
  • Some participants may receive access to an investigational treatment, which is still being studied.
  • Your participation helps researchers learn whether this approach could help future patients.

About this study

In plain language

This study uses current and future information from people with non-small cell lung cancer to create groups for comparison in research. It is for adults whose cancer has spread to nearby tissues or to other parts of the body.

A study to create control arms using current and future information in patients with lung cancer.

Compensation is read from the study's own description and may be missing — always confirm with the study team.

Eligibility

Who can join

  • Be older than 18 when you sign the consent form.
  • Have non-small cell lung cancer confirmed by lab testing that has spread nearby or to other parts of the body.
  • Be fully active or able to do light work, even if hard physical activity is limited, within 4 weeks before starting the treatment being studied.
  • Be expected to live more than 3 months.
  • Be able to understand and sign the study consent form.
  • Have cancer that the study doctor can measure on available scans, such as CT, MRI, or PET scans.
  • Other rules may apply to your study group. These are listed in the study plan.

Who can't join

  • Be taking part in a clinical trial of an experimental drug.
  • Be receiving treatment that works throughout the body for another cancer.
  • Be able to receive treatment meant to cure your cancer.
  • Other rules may apply to your study group. These are listed in the study plan.

Simplified for readability. The official criteria below are what the study team uses.

Official eligibility criteria

Inclusion Criteria: 1. \> 18 years of age at the time of informed consent 2. Pathologically confirmed locally advanced or metastatic NSCLC 3. ECOG Performance of less than or equal to 1 within 4 weeks prior to starting index therapy. 4. Life expectancy of more than 3 months 5. Able to understand and sign informed consent 6. Evidence of measurable disease (as assessed by the Investigator) on available imaging (e.g CT, MRI, PET) \*see protocol for cohort specific inclusion criteria\* Exclusion Criteria: 1. Actively on a clinical trial of an investigational agent 2. Currently receiving active systemic therapy for another malignancy 3. Eligible for treatment with curative intent \*see protocol for cohort specific exclusion criteria\*

Study sites (11)

CA

DE

IL

NM

NY

PA

TX